These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36152286)

  • 1. Profiling of Multiple Matrix Metalloproteinases Activities in the Progression of Osteosarcoma by Peptide Microarray-Based Fluorescence Assay on Polymer Brush-Coated Zinc Oxide Nanorod Substrate.
    Wang Z; Jian M; Li X
    Methods Mol Biol; 2023; 2578():161-175. PubMed ID: 36152286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a peptide microarray-based metal-enhanced fluorescence assay for ultrasensitive detection of multiple matrix metalloproteinase activities by using a gold nanorod-polymer substrate.
    Jian M; Sun X; Zhang H; Li X; Li S; Wang Z
    Biosens Bioelectron; 2024 Feb; 246():115871. PubMed ID: 38035516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Matrix Metalloproteinase Inhibition by Peptide Microarray-Based Fluorescence Assay on Polymer Brush Substrate and in Vivo Assessment.
    Lei Z; Chen H; Zhang H; Wang Y; Meng X; Wang Z
    ACS Appl Mater Interfaces; 2017 Dec; 9(50):44241-44250. PubMed ID: 29190077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide Array-Based In Situ Fluorescence Assay for Profiling Multiple Matrix Metalloproteinase Activities.
    Lei Z; Wang Z
    Methods Mol Biol; 2023; 2578():177-189. PubMed ID: 36152287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
    Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z
    J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(glycidyl methacrylate-co-2-hydroxyethyl methacrylate) Brushes as Peptide/Protein Microarray Substrate for Improving Protein Binding and Functionality.
    Lei Z; Gao J; Liu X; Liu D; Wang Z
    ACS Appl Mater Interfaces; 2016 Apr; 8(16):10174-82. PubMed ID: 27049528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calprotectin inhibits matrix metalloproteinases by sequestration of zinc.
    Isaksen B; Fagerhol MK
    Mol Pathol; 2001 Oct; 54(5):289-92. PubMed ID: 11577169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
    Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
    Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro.
    Shang HS; Chang JB; Lin JH; Lin JP; Hsu SC; Liu CM; Liu JY; Wu PP; Lu HF; Au MK; Chung JG
    Molecules; 2014 Oct; 19(10):16588-608. PubMed ID: 25322282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2013 Oct; 43(4):1027-35. PubMed ID: 23900236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risedronate inhibits human osteosarcoma cell invasion.
    Xin ZF; Kim YK; Jung ST
    J Exp Clin Cancer Res; 2009 Jul; 28(1):105. PubMed ID: 19624845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crude extract of Corni Fructus inhibits the migration and invasion of U-2 OS human osteosarcoma cells through the inhibition of matrix metalloproteinase-2/-9 by MAPK signaling.
    Liao CL; Lin JH; Lien JC; Hsu SC; Chueh FS; Yu CC; Wu PP; Huang YP; Lin JG; Chung JG
    Environ Toxicol; 2015 Jan; 30(1):53-63. PubMed ID: 23955962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide Microarray-Based Metal Enhanced Fluorescence Assay for Multiple Profiling of Matrix Metalloproteinases Activities.
    Lei Z; Zhang H; Wang Y; Meng X; Wang Z
    Anal Chem; 2017 Jun; 89(12):6749-6757. PubMed ID: 28516765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
    Liu Z; Ivanoff A; Klominek J
    Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
    Keeling J; Herrera GA
    Kidney Int; 2005 Oct; 68(4):1590-603. PubMed ID: 16164636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.